Combination therapy for multiple sclerosis: the treatment strategy of the future?

CNS Drugs
Bianca Weinstock-Guttman, Rohit Bakshi

Abstract

Multiple sclerosis (MS) is an inflammatory autoimmune disease characterised by demyelination and axonal loss in the CNS. Although new immunomodulatory therapies including interferon-beta and glatiramer acetate became available during the last decade, these therapies are only partially effective. There is a continuing need to develop more effective treatment strategies to combat the chronic and progressive aspects of the disease. In view of the complex pathophysiology underlying the MS disease process, combination therapy offers a rational therapeutic approach. Combining immunomodulatory agents with different mechanisms of action that promote synergistic or additive effects represents an important objective in MS therapeutic research. Ultimately, the optimal therapies will likely include strategies that promote repair and limit tissue destruction in combination with anti-inflammatory interventions.

References

Oct 26, 1991·Lancet·P L YudkinC Milanese
Jan 1, 1995·Annals of Neurology·B Weinstock-GuttmanR A Rudick
Jun 26, 1998·Immunology Today·P C Calder
Nov 6, 1998·Journal of the Neurological Sciences·P B Andersson, D E Goodkin
Mar 24, 1999·Trends in Neurosciences·J J ArchelosH P Hartung
Jan 5, 2000·The American Journal of Clinical Nutrition·M J JamesL G Cleland
Jun 13, 2001·Neurology·UNKNOWN Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group
Jun 27, 2001·Neurology·UNKNOWN PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group.
Sep 11, 2001·Multiple Sclerosis : Clinical and Laboratory Research·M ChenS Dhib-Jalbut
Feb 9, 2002·Annals of Neurology·Natalija PopovicIan D Duncan
May 23, 2002·Brain : a Journal of Neurology·Veronika BrundulaV Wee Yong
Jun 22, 2002·Annals of the New York Academy of Sciences·Bin LiuJau-Shyong Hong
Jun 22, 2002·Brain : a Journal of Neurology·Claudia F LucchinettiHans Lassmann
Sep 11, 2002·Neurology·J A CohenUNKNOWN IMPACT Investigators
Sep 27, 2002·Annals of Neurology·Nancy L SicotteRhonda R Voskuhl

❮ Previous
Next ❯

Citations

May 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jose C Masdeu, Rohit Bakshi
May 15, 2007·Current Opinion in Neurology·Fiona CostelloElliot Frohman
Jun 1, 2006·CNS Drugs·Noel G Carlson, John W Rose
Aug 23, 2012·Neurological Research·Veronika TichaEva Havrdova
Mar 24, 2016·Therapeutic Advances in Neurological Disorders·Steven J GreenbergRohit Bakshi
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Hans-Peter Hartung
Nov 1, 2008·Nature Reviews. Drug Discovery·Rocio S Lopez-Diego, Howard L Weiner
Aug 11, 2005·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·Vilmos AgostonSándor Pongor
Jun 11, 2020·Multiple Sclerosis and Related Disorders·H CheraghmakaniM Ghazaeian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.